Related Experiment Video
Updated: May 6, 2026

Assessment of Kidney Function in Mouse Models of Glomerular Disease
Published on: June 30, 2018
C3 glomerulopathy: consensus report
Matthew C Pickering1, Vivette D D'Agati, Carla M Nester
1Centre for Complement and Inflammation Research, Imperial College London, London, UK.
C3 glomerulopathy, a kidney disease marked by C3 protein buildup, needs a clear definition and diagnostic approach. Experts convened to establish consensus on its definition, complement testing, and therapeutic strategies.
Area of Science:
- Nephrology and Renal Pathology
- Complement System Biology
Background:
- C3 glomerulopathy is defined by C3 accumulation in glomeruli with minimal immunoglobulin deposition.
- Recent advancements necessitate a refined understanding and consensus on this pathological entity.
Framework:
- First C3 Glomerulopathy Meeting convened experts in renal pathology, nephrology, and complement biology.
- Objectives included defining C3 glomerulopathy, standardizing complement investigations, and exploring therapeutic avenues.
Implementation:
- The meeting report reflects the expert group's current consensus view.
- Focus on establishing a unified definition and diagnostic criteria.
Implications:
- A consensus framework will guide future research and clinical management of C3 glomerulopathy.
- Standardized investigations and therapeutic exploration are crucial for patient outcomes.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Nephrotic Syndrome II : Assessment and Medical Management
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome III : Nursing Management
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Glaucoma: Overview

